Discover the detailed record of transactions filed by 김효기, Chief Executive Officer. Director active across 2 companies, notably 셀레믹스. In total, 30 filings have been logged. History available since 6 March 2026. The latest transaction was filed on 7 May 2026 (Purchase). Regulator: DART (FSS). The full history is accessible without signup.
Companies and markets linked to 김효기
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Kim Hyo-Ki is the Co-CEO of Selemix, an innovative company in the biotechnology sector. He shares responsibility for the strategic and operational leadership of the company. His role is essential for the development of new technologies and the improvement of products offered by Selemix.